| Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients--current status and future options. | |
| | |
MedLine Citation:
|
PMID: 17933437 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Inhibition of gastrointestinal motility is a major problem in critically ill patients. Motor stasis gives rise to subsequent complications including intolerance to enteral feeding, enhanced permeability of the atrophic intestinal mucosa and conditions as severe as systemic inflammatory response syndrome, sepsis and multiple organ failure. Although the diagnosis of motility disturbances in critically ill patients is difficult, the type and site of the disturbance are important to consider in the analysis of the condition and in the choice of therapeutic approach. The pharmacological treatment of impaired gastrointestinal motility is difficult to handle for the clinician, because the underlying mechanisms are complex and not fully understood and the availability of pharmacological treatment options is limited. In addition, there is a lack of controlled studies on which to build an evidence-based treatment concept for critically ill patients. Notwithstanding this situation, there has been remarkable progress in the understanding of the integrated regulation of gastrointestinal motility in health and disease. These advances, which largely relate to the organization of the enteric nervous system and its signaling mechanisms, enable the intensivist to develop a standardized concept for the use of prokinetic agents in the treatment of impaired gastrointestinal motility in critically ill patients. |
| | |
Authors:
|
Michael K Herbert; Peter Holzer |
Related Documents
:
|
7359597 - Hyperosmolality in the burn patient: analysis of an osmolal discrepancy. 11535907 - Association of hyperglycemia with increased mortality after severe burn injury. 17184647 - Is extracorporeal life support contraindicated in elderly patients? 109057 - The septic burned patient: a model for studying the role of complement and immunoglobul... 20636287 - Abnormal mechanisms of antisaccade generation in schizophrenia patients and unaffected ... 9416807 - 1h magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal ... |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-10-22 |
Journal Detail:
|
Title: Clinical nutrition (Edinburgh, Scotland) Volume: 27 ISSN: 1532-1983 ISO Abbreviation: Clin Nutr Publication Date: 2008 Feb |
Date Detail:
|
Created Date: 2008-02-12 Completed Date: 2008-03-17 Revised Date: 2011-04-06 |
Medline Journal Info:
|
Nlm Unique ID: 8309603 Medline TA: Clin Nutr Country: England |
Other Details:
|
Languages: eng Pagination: 25-41 Citation Subset: IM |
Affiliation:
|
Department of Anaesthesiology, University of Wuerzburg, Oberduerrbacher Str. 6, 97080 Wuerzburg, Germany. Herbert_M@klinik.uni-wuerzburg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Critical Illness* Dietary Fiber / administration & dosage Evidence-Based Medicine Gastrointestinal Agents / therapeutic use* Gastrointestinal Motility / drug effects*, physiology* Gastrointestinal Transit / drug effects, physiology Humans Intestinal Diseases / prevention & control, therapy* Probiotics |
| Grant Support | |
ID/Acronym/Agency:
|
L 25-B05//Austrian Science Fund FWF |
| Chemical | |
Reg. No./Substance:
|
0/Gastrointestinal Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro an...
Next Document: A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of ...